KNIGHT JEFF E. (Chief Operating Officer) sold 8.1% of their position (9.91K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $370.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/18/2026ACC: 0001628280-26-019503
Officer· Chief Operating Officer
Since Aug 2021
-9.91K
Net shares
Net seller
$370.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.91K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.95K
Price / share
$37.11
Trade value
$220.80K
% of position
4.9%
3/16/2026
121.93K→115.98K
Common Stock
Direct
Shares
−3.96K
Price / share
$37.77
Trade value
$149.61K
% of position
3.4%
3/16/2026
115.98K→112.02K
Total
Net shares
−9.91K
Net value
-$370.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | S · Sale | −5.95K | $37.11 | $220.80K | 4.9% | 121.93K | 115.98K |
| Common Stock Direct | 3/16/2026 | S · Sale | −3.96K | $37.77 | $149.61K | 3.4% | 115.98K | 112.02K |
| Total | −9.91K | -$370.41K | ||||||
Derivative Transactions0
No derivative transactions reported